IPO Boutique

Dova Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Dova Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Dova Pharmaceuticals, Inc.DOVA -
NASDAQ
$15.00-$17.00 $17.00 $19.254.41 million6/29/2017
J.P. Morgan, Jefferies, Leerink Partners
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-06-02
Terms Added 2017-06-19



Dova Pharmaceuticals, Inc. Quote & Chart - Click for current quote - DOVA

About Dova Pharmaceuticals, Inc. (adapted from Dova Pharmaceuticals, Inc. prospectus):
They are a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "DOVA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved